Cresset January 2023 Newsletter
After a busy start to 2023, our January monthly update newsletter includes features around Flare Visualizer, Virtual Screening, Molecular Dynamics, and more!
Hat trick for cofinitive in New Year Honours listing
With such a flourishing tech cluster in Cambridge, it is with huge delight that cofinitive is listed as #1 for the third year running for leading the area as Image Maker for many of our entrepreneurial tech companies.
Skilled Worker Visa Extension - Guide for Employers
Skilled Worker visas are issued for a period of up to five years. To remain in the UK beyond this, the worker has to make an application for a Skilled Worker visa extension before their current visa expires.
Charity walks raises more than £30,000 for local charities
Cambridge’s iconic annual Bridge the Gap charity walk raised more than £30,000 for two local charities in its first in-person event since before Covid.
Growth Works helps Cambridge business boost turnover and create new jobs
A successful Cambridge engineering company has thanked Growth Works for helping them secure a grant of £138,000 towards state-of-the-art equipment, boosting production and creating local jobs.
Measuring the dew point for nitrogen and oxygen in gas generators
For many companies, there are considerable advantages to using industrial gas generators, rather than traditional bottled or tanker supply to on-site silos. However, the benefits only accrue if the gas generator is operating at optimum levels of efficiency and reliability.
How much do you know about cloud security?
The growth of cloud computing has completely changed the way many of us work. It’s also changed the way we need to think about security.
Efficiently define complex atom picks for analysis and visualization of your protein-ligand systems
Understanding ligand-protein interactions through visualization is an essential part of scientific reasoning and is a crucial decision-making process that computational and medicinal chemists routinely use.
Carbon Orange - Now we are six
Carbon Orange writes: It's been a while since our last update, but now seems like a good time to pop back so you can celebrate our 6th birthday with us!
University of Exeter enters virtual screening collaboration with Cresset Discovery to accelerate discovery of novel antimicrobial drugs
Cresset Discovery, provider of molecular modeling expertise for drug discovery, is collaborating with the University of Exeter to find new antimicrobial drugs.
Harlow businesswoman smashes targets thanks to support from pioneering business growth service
A Harlow businesswoman is going from strength to strength thanks to funding and mentoring from one of the country’s largest economic development initiatives of its kind, Growth Works
The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced that the U.S.
Key Amnesty campaign to tackle misused Council properties in South Cambridgeshire
People who are misusing Council properties are being offered a one-off opportunity to #DoTheRightThing and return their keys without facing criminal proceedings during a month-long crackdown by South Cambridgeshire District Council.
TTP introduces Cellular Origins, a TTP Company focussed on delivering scalable manufacture of cell and gene therapies
TTP plc (TTP), a leading independent technology and product development company, has today announced the launch of Cellular Origins, a TTP Company. Cellular Origins is a TTP spin-out, created to enable scalable, cost-effective and efficient manufacture of cell and gene therapies.
Avacta Announces Successful Completion of Fourth Dose Escalation in AVA6000 Phase 1 Clinical Study
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics announces that AVA6000 continues to show a very favourable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation phase 1 clinical trial.
Brew Monday
This Brew Monday, the Samaritans charity is reminding everyone to reach out for a cuppa and a catch-up with family, friends, colleagues and neighbours. It’s a simple but great way for people to stay connected and help avoid feelings of loneliness and isolation. Reaching out to someone y
The scent of success in public speaking
Can the scent you wear help you perform at your peak in a presentation? This experience suggests so…
CUH neurosurgeon wins prestigious Hunterian Professorship award
A consultant neurosurgeon from Addenbrooke’s Hospital has been given a prestigious award for his cutting-edge research into traumatic brain injury.
Tom’s Trust spread Christmas cheer to children in hospital
From superhero capes to books and cuddly soft toys, children were treated to some wonderful gifts from Tom’s Trust while spending time in hospital over the Christmas period.
The year in review: Updates and trends
In 2022, everyone witnessed intense activity in matters related to supply chain issues, the energy transition, oil & gas, post-M&A disputes, licensing issues, breaches of distribution contracts and increasingly arbitrations deriving from geopolitical issues in Europe and Asia and from com
Investors - Come and meet the next big things in impact innovation
From fields such as food waste reduction, transforming plastic into low-carbon building products to building nature-related intelligence gathering - all of the ventures on the Allia Accelerator Challenge are addressing global challenges in innovative ways. And they want you to meet them!
Scott Bradbury explores learning trends for 2023
Digital learning services provider, Scott Bradbury, launches its Dolphin Forum to provide new networking opportunity for customers and consultant partners.
Arecor announces transfer of AT307 to Hikma
License milestone to develop and commercialise ready-to-use medicine achieved. Arecor regains rights to AT282 following portfolio review at Hikma.